Stock Information
Lyell Immunopharma Inc (LYEL)
Ticker Symbol: LYEL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $407.39 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -12.9752
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -85.71%
Latest News
-
Citizens Reiterates Market Outperform on Lyell Immunopharma, Maintains $34 Price Target
Mon, Jun 15, 2026 10:03 AM
-
Needham Reiterates Buy on Lyell Immunopharma, Maintains $44 Price Target
Mon, Jun 15, 2026 6:06 AM
-
Lyell Immunopharma: Undervalued Ahead Of A Major CAR-T Inflection
Sat, Jun 13, 2026 12:23 PM
-
Lyell Immunopharma Announces Data From Its Phase 1/2 Clinical Study Of Rondecabtagene Autoleucel In Participants With Relapsed Or Refractory Large B-cell Lymphoma Shows Manufacturing Success Rate Of 97%
Fri, Jun 12, 2026 12:53 PM
Key Financials
Financial data not available
